1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA N4BP2 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA ATAD5 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA PHIP CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA MED12 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA SPIN4 CTRPv2 pan-cancer AAC 0.16 3e-07
mRNA ZNF610 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA NBPF10 CTRPv2 pan-cancer AAC -0.16 3e-07
mRNA CTC-273B12.7 CTRPv2 pan-cancer AAC 0.16 3e-07
mRNA SOGA3 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA SCGB2B2 CTRPv2 pan-cancer AAC 0.16 3e-07
Download CSV